Previous Nav
Net Change on 24-04-2025
PersonalFN Rating
Category
Assets (Cr.)
Expense Ratio
Fund House
Launch Date
Benchmark
Minimum Investment (₹)
Minimum Addl Investment (₹)
Exit Load (%)
Minimum SIP Investment (₹)
Minimum STP Investment (₹)
Minimum SWP Investment (₹)
52 Week Low Nav (₹)
52 Week Low Nav Date
52 Week High Nav (₹)
52 Week High Nav Date
Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised
Sun Pharmaceutical Industries Ltd.
Dr. Reddy's Laboratories Ltd.
Cipla Ltd.
Divi's Laboratories Ltd.
Aurobindo Pharma Ltd.
Lupin Ltd.
Alkem Laboratories Ltd.
Mankind Pharma Ltd
Gland Pharma Ltd.
Zydus Lifesciences Ltd.
Apollo Hospitals Enterprise Ltd.
Syngene International Ltd.
Atul Ltd.
Windlas Biotech Ltd.
Pfizer Ltd.
Alembic Pharmaceuticals Ltd.
Medplus Health Services Ltd
SBI Life Insurance Company Ltd.
Biocon Ltd.
Advanced Enzyme Technologies Ltd.
TREPS
Medi Assist Healthcare Services Ltd
Shilpa Medicare Ltd.
Fine Organic Industries Ltd.
Glenmark Pharmaceuticals Ltd.
Sanofi Consumer Healthcare India Ltd
Astrazeneca Pharma India Ltd.
Aarti Industries Ltd.
Thyrocare Technologies Ltd.
Yatharth Hospital & Trauma Care Services Pvt Ltd
Aarti Drugs Ltd.
FDC Ltd.
Sun Pharma Advanced Research Co. Ltd
Procter & Gamble Health Ltd.
Max Financial Services Ltd.
Senores Pharmaceuticals Ltd
Star Health & Allied Insurance
Emcure Pharmaceuticals Ltd.
Unichem Laboratories Ltd.
Alivus Life Sciences Ltd.
Laxmi Organic Industries Ltd.
Laxmi Dental Ltd.
Cash Margin - Derivatives
Net Current Assets
Galaxy Surfactants Ltd.
Pharmaceuticals & Drugs
Hospital & Healthcare Services
Chemicals
Business Support
Insurance
Miscellaneous
Finance - Others
Medical Equipment/Supplies/Accessories
Household & Personal Products
Cash
Equity
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to ICICI Prudential Mutual Fund. It was launched on 13-Jul-2018 and currently has an AUM of ₹4,914.64 crore. ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is benchmarked against BSE Health Care - TRI as primary index and NIFTY 50 - TRI as secondary index.
The NAV of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund ended up ₹0.28(0.69%)yesterday to ₹40.68.
Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and
The ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund is managed by Dharmesh Kakkad .
One BKC, A - Wing 13th Floor, Bandra Kurla Complex, Bandra (East) Mumbai - 400 051